Pacific Diabetes Technologies

Portland, OR · Founded 2013 · Privately Held (backing)

Developer of hollow glucose sensor devices designed for continuous glucose monitoring and insulin delivery. Pacific Diabetes Technologies is based in Portland, OR and was founded in 2013. Its last reported valuation was $30.7 million in Mar 2025. It has raised $17.6 million across 3 recorded rounds; the latest was a $3.4 million seed round in Oct 2025.

Last reported valuation
$30.7M
Oct 2026
Priced at
—
Total raised
$17.6M
Last round
Seed Round
Oct 2025

Who backs Pacific Diabetes Technologies?

6 investors
InvestorType
National Institutes of HealthOther
Breakthrough T1DOther
The Leona M. and Harry B. Helmsley Charitable TrustOther
National Institute of Diabetes and Digestive and Kidney Diseases—
Portland State University Business Accelerator—
TMD Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Pacific Diabetes Technologies investors

6 investors are on record for Pacific Diabetes Technologies, including National Institutes of Health, Breakthrough T1D, The Leona M. and Harry B. Helmsley Charitable Trust and National Institute of Diabetes and Digestive and Kidney Diseases. The seed round in Oct 2025 drew 15 investors.

Free account
More of Pacific Diabetes Technologies with a free account
  • ·Watch Pacific Diabetes Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Pacific Diabetes Technologies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View